L2M – Development of a Rapid Molecularly Imprinted Polymer (MIP)-Based Diagnostic Device for Differentiating Bacterial and Viral Infections via Dual Biomarker Detection

We are developing a rapid, low-cost diagnostic device that helps healthcare providers quickly determine whether an infection is bacterial or viral, leading to better treatment decisions and reduced antibiotic misuse. This project will explore real-world demand for the device, evaluate its competitive edge, and refine its market strategy. Through the Lab2Market Validate program, Edmonton Unlimited will support the translation of university-based research into practical healthcare solutions, contributing to the development of a stronger and more effective health innovation landscape in Alberta and beyond.

Faculty Supervisor:

Amir Sanati Nezhad

Student:

Partner:

Edmonton Unlimited

Discipline:

Engineering

Sector:

Professional, scientific and technical services; Public administration

University:

University of Calgary

Program: